Abstracts

837 – Decreased Anti-Inflammatory Tryptophan Metabolites Correlate With Higher CVD Risk in PWH

Background Distinct inflammatory profiles have been associated with increased prevalence of cardiovascular disease (CVD) in people with HIV (PWH). Alterations in tryptophan metabolism through the kynurenine pathway (KP) have also been observed in PWH and are associated with CVD. We aimed to explore relationships between KP metabolites and inflammatory profiles of PWH. Methods In the…

815 – Readmission Risk for Adults With HIV Hospitalized for Heart Failure or Acute Myocardial Infarction

Background People with HIV (PWH) have a higher incidence of cardiovascular disease, including heart failure (HF) and acute myocardial infarction (AMI) than people without HIV (PWoH). In the general population, 30-day readmissions following hospitalizations for HF and AMI are common, and reducing these readmissions is a national quality of care priority. This study compares the 30-day…

853 – Time-Updated Win Ratio Aligns With Primary REPRIEVE Findings and Suggests Early Pitavastatin Benefit

Background REPRIEVE demonstrated a 36% reduction in the hazard of major adverse cardiovascular (CV) events (MACE) among those randomized to pitavastatin vs placebo using a time-to-first-event (TTFE) analysis. TTFE results can be difficult to interpret with CV composite endpoints, as “less severe” events (MI and stroke) are likely to precede “more severe” events (death). Win…

832 – Cardiovascular Risk Assessment in Women Living With and Without HIV Using the PREVENT Model

Background Cardiovascular disease (CVD) risk in women living with HIV (WLWH) is shaped not only by traditional risk factors, but also by HIV-specific and women-specific factors. Primary prevention of CVD utilizes risk assessment models that show varying performance in WLWH. Predicting Risk of cardiovascular disease EVENTs (PREVENT) is a novel race/ethnicity-free sex-specific calculator that estimates…

788 – Viral and Host Proteins Carried by Exosomes From PLWH Could Play a Role as Triggers of NADCs

Background A higher incidence and more rapid progression of several types of non-AIDS-defining cancer (NADC) have been reported in people living with HIV (PLWH). However, the exact mechanism linking HIV-1 infection to the development of NADCs is not yet fully understood. In vitro studies have suggested that viral molecules carried by exosomes derived from HIV-1-infected…

794 – Causes of Death Among Adults With HIV-Associated Kaposi Sarcoma in East Africa in the Treat All Era

Background In East Africa, one-year mortality following a diagnosis of HIV-associated Kaposi sarcoma (KS) in the Treat All era was recently estimated, in a community-derived sample, to be 41%.  To date, there is limited information on why these patients die.  Understanding causes of death among adults diagnosed with KS might improve management and, hence, survival or…